![](/img/cover-not-exists.png)
A Phase I/II Placebo-Controlled Trial of C1 Inhibitor for Prevention of Antibody-Mediated Rejection in HLA Sensitized Patients.
Vo, A., Choi, J., Cisneros, K., Kahwaji, J., Peng, A., Villicana, R., Jordan, S.Volume:
98
Journal:
Transplantation
DOI:
10.1097/00007890-201407151-00318
Date:
July, 2014
File:
PDF, 344 KB
2014